このエントリーをはてなブックマークに追加


ID 34230
フルテキストURL
著者
Kobayashi, Makoto Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nakamura, Kazufumi Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons researchmap
Kusano, Kengo Fukushima Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nakamura, Yoichi aDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ohta-Ogo, Keiko Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nagase, Satoshi aDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sakuragi, Satoru Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ohe, Tohru Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
抄録

Immunological factors have been involved in the pathogenesis of dilated cardiomyopathy (DCM). The cytotoxic action of macrophages is one of the main factors causing cardiac myocyte damage. Monocyte chemoattractant protein-1 (MCP-1) is a major signal for the accumulation of monocytes/macrophages. We examined whether MCP-1 was expressed in the myocardium of DCM patients and whether the expression level was correlated with the degree of impairment of cardiac function. The expression of MCP-1 in the myocardium was determined by immunohistochemistry in endomyocardial biopsy samples from 13 patients. The expression of MCP-1 was found in all myocardial samples from DCM patients but not in those from control subjects. Positive staining for MCP-1 was distinct in cardiac myocytes, interstitium and infiltrating cells. Semi-quantitative analysis revealed that the expression of MCP-1 was inversely correlated with left ventricular ejection fraction. In conclusion, the expression level of MCP-1 in the myocardium was correlated with the degree of impairment of cardiac function in patients with DCM.

キーワード
cardiomyopathy
immunohistochemistry
monocyte
備考
Published with permission from the copyright holder.
This is a author's copy,as published in International Journal of Cardiology, 2008 Vol.126 Issue.3 pp.427-429
Publisher URL: http://dx.doi.org/10.1016/j.ijcard.2007.01.109
Direct access to Thomson Web of Science record
Copyright © 2008 Elsevier Ireland Ltd.
発行日
2008-06-22
出版物タイトル
International Journal of Cardiology
126巻
3号
開始ページ
427
終了ページ
429
資料タイプ
学術雑誌論文
言語
英語
査読
有り
DOI
Web of Science KeyUT
Submission Path
cardiovascular_diseases/2